Global law firm Clifford Chance has advised The Paragon Fund III GmbH & Co. geschlossene Investment KG (“Paragon”) on the sale of Primed Group to Inflexion. Primed is a leading provider of medical devices and sterilization services headquartered in Halberstadt, Germany. The closing of the transaction is subject to customary closing conditions.
As a developer, manufacturer, sterilization service provider and distributor, Primed Group covers the entire value chain and offers an innovative and high-quality product portfolio in the areas of tracheostomy and laryngectomy, wound drainage, thoracic surgery and stool management systems.
The Clifford Chance team led by partners Mark Aschenbrenner and Volkmar Bruckner and included associate Veronika Müller (all Private Equity, Munich), partner Torsten Syrbe and senior associate Marlene Kießling (both Healthcare, Dusseldorf), partner Thomas Voland and senior associate Laura-Isabell Dietz (both Regulatory, Dusseldorf), partner Dominik Engl (Tax, Frankfurt), partner Christopher Fischer and associate Anna-Celine Brill (Employment, Frankfurt), partner (Germany) Gerson Raiser and associate Carla Schön (Compliance, Frankfurt), counsel Nicolas Hohn-Hein (IP, Dusseldorf) and partner Dimitri Slobodenjuk and counsel Arne Gayk (both Antitrust, Dusseldorf) as well as partner Michal Jasek, counsel Veronika Kinclova and associate Natalie Kurkova (all Corporate, Prague).
Christian Ritschka from the Austrian firm Dorda provided advice on Austrian law.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.
